Holdings
B Group, Inc.
As of Jun 30, 2026, B Group, Inc. reported 17 positions worth US$169M. Largest: Adma Biologics Inc, Palisade Bio, Inc. and Nrx Pharmaceuticals, Inc. What it bought and sold, with each filing.
| Company | Shares | Value as reported | Change | As of |
|---|---|---|---|---|
| Adma Biologics Inc | 3.26M | US$27.3M | +55,000 | Jun 30, 2026 |
| Palisade Bio, Inc. | 11.4M | US$23.9M | no change | Jun 30, 2026 |
| Nrx Pharmaceuticals, Inc. | 4.09M | US$16.7M | +1.09M | Jun 30, 2026 |
| Sensei Biotherapeutics, Inc. | 610K | US$15.3M | new | Jun 30, 2026 |
| Taysha Gene Therapies, Inc. | 1.8M | US$12.3M | no change | Jun 30, 2026 |
| Praxis Precision Medicines, Inc. | 33,237 | US$11.1M | no change | Jun 30, 2026 |
| Cellectis S.a. | 3.28M | US$9.84M | no change | Jun 30, 2026 |
| Zai Lab Ltd. | 451K | US$8.56M | no change | Jun 30, 2026 |
| Oruka Therapeutics, Inc. | 75,000 | US$7.14M | no change | Jun 30, 2026 |
| Iovance Biotherapeutics, Inc. | 1.5M | US$6.24M | no change | Jun 30, 2026 |